Main Industry
Biotechnology
Main Product/Service
*Botanical New Drug*
The main therapeutic area we are focusing on is dermatology. With the aim of improving the quality of life for patients, we develop products with market profitability and improved clinical effectiveness for patients in different age g
The main therapeutic area we are focusing on is dermatology. With the aim of improving the quality of life for patients, we develop products with market profitability and improved clinical effectiveness for patients in different age g
Founded Year
2014
Unified Business No.
24558245
Status
Active
Number of Employees
0
Total Paid-in
Capital
345,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in 2014, Xantho Biotechnology is dedicated to the development of botanical new drugs with low side effects from naturally derived materials, with the aim of providing new medications with improved clinical efficacy and to those with unmet medical needs. We are targeting at the botanical drug market with a global market size worth more than 40 billion USD.
